GSA Capital Partners »

Lipocine shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Lipocine (LPCN) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Lipocine

Tip: Access up to 7 years of quarterly data

All positions including Lipocine held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lipocine by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $48k 19k 2.57

More positions owned by GSA Capital Partners

Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Spdr Series Trust St Shor Corp Etf (SPSB)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Agree Realty Corporation (ADC)
Bank Ozk (OZK)
PNM Resources (TXNM)
Essential Properties Realty reit (EPRT)
TJX Companies (TJX)
Everest Re Group (EG)
O'reilly Automotive (ORLY)
American Airls (AAL)
Medtronic SHS (MDT)
Northrop Grumman Corporation (NOC)

View all positions for GSA Capital Partners

Top funds holding Lipocine

Squadron Capital Management
Ikarian Capital
Eversept Partners
Vanguard Capital Management
Acadian Asset Management
Boothbay Fund Management
Jane Street
BlackRock
Two Sigma Investments
Citadel Advisors
Seven Fleet Capital Management
Geode Capital Management
Renaissance Technologies
Vanguard Fiduciary Trust
Dimensional Fund Advisors

View all funds holding Lipocine